Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12858292 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Albright Hereditary Osteodystrophy: Growth Hormone Trial and Cognitive/Behavioral Assessments
Conditions: Pseudohypoparathyroidism Type 1a;   Albright Hereditary Osteodystrophy
Interventions: Drug: Growth hormone;   Drug: Growth Hormone

Study has passed its completion date and status has not been verified in more than two years.